Walaa H. Maadawy-El
Giza, GZ 12411, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Azithromycin Mitigates Experimental Cryptosporidiosis-Driven Ileocecal Adenocarcinoma by Modulating Autophagy, Apoptosis, and PI3K/AKT Signaling.
Journal: Biomedicines
Published: April 12, 2026
Integrating CTLA-4 Genetics and Soluble Isoforms for the Stratification of HCV-Related Hepatocellular Carcinoma Risk and Aggressiveness.
Journal: International journal of molecular sciences
Published: October 18, 2025
Correction: Ghareeb et al. Chemical Profiling of Polyphenolics in Eucalyptus globulus and Evaluation of Its Hepato-Renal Protective Potential Against Cyclophosphamide Induced Toxicity in Mice. Antioxidants 2019, 8, 415.
Journal: Antioxidants (Basel, Switzerland)
Published: September 03, 2025
Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 17, 2025
Niclosamide modulates chronic Cryptosporidium-induced ileocecal adenocarcinoma in immunocompromised infected mice via targeting IL-6/IL-22-STAT3 axis.
Journal: Research in veterinary science
Published: August 06, 2025
Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis.
Journal: Biomedicines
Published: August 02, 2025
Ticagrelor attenuates cholestasis-induced liver fibrosis by inhibiting S1PR2-dependent Akt/ERK signaling, NLRP3 inflammasome activation.
Journal: International immunopharmacology
Published: July 18, 2025
Forskolin alleviates cholestatic liver disease by inhibiting the Hippo/YAP-mediated ductular reaction and fibrosis progression.
Journal: European journal of pharmacology
Published: May 30, 2025
Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.
Journal: Scientific reports
Published: March 17, 2025
Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases.
Journal: International immunopharmacology
Published: February 01, 2025
Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model.
Journal: Drug delivery and translational research
Published: May 07, 2022
Last Updated: 09/26/2026